Description
This enduring material will discuss "New Tools for Electrophysiologists: The Treatment of Central
Sleep Apnea in Heart Failure Patients". This continuing medical education activity is supported in part by an educational grant from Respicardia.
Planning Committee
The following planning committee members has relevant financial relationships with commercial interests to disclose that would influence their development of content for this activity; their educational unit does not have a financial interest or affiliation with an organization that may receive direct benefit from the subject of the proposed CME activity; and they will not be personally compensated for their role in the planning or execution of this proposed CME activity by an organization other than The Ohio State University:
William Abraham, MD, discloses he has relationships with commercial interests in the following areas: Advisory Board Membership - Abbott, Boehringer Ingelheim, Medtronic, Novartis, and Respicardia; and Editorial Board Involvement – JACC-HF, JWC, PACE. His educational unit does not have a financial interest or affiliation with an organization that may receive direct benefit from the subject of this CME activity. He will not be personally compensated for his role in the planning or execution of this CME activity by an organization other than The Ohio State University. Her role in the planning
process was limited to discussing evidence only from unbiased reviews of the literature.
Ralph Augostini, MD, discloses he has relationships with commercial interests in the following
areas: Grant/Research Support - Respicardia; and Consultant/Speaker Bureau – Respicardia. His educational unit does not have a financial interest or affiliation with an organization that may
receive direct benefit from the subject of this CME activity. He will not be personally compensated for his role in the planning or execution of this CME activity by an organization other than The Ohio State University. Her role in the planning process was limited to discussing evidence only from unbiased
reviews of the literature.
Speakers Disclosures
The following speaker has no relevant financial relationships with commercial interests to disclose that would influence their development of content for this activity; their educational unit does not have a financial interest or affiliation with an organization that may receive direct benefit from the subject of the proposed CME activity; and they will not be personally compensated for their role in the planning or execution of this proposed CME activity by an organization other than The Ohio State University:
James Mann, MD
The following speakers have relevant financial relationships with commercial interests that could influence their development of content for this activity; their educational unit does not have a financial interest or affiliation with any organization that may receive direct benefit from the subject of the proposed CME activity; and they will not be personally compensated for their role in the planning or execution of this proposed CME activity by an organization other than The Ohio State University:
William Abraham, MD, discloses he has relationships with commercial interests in the following
areas: Advisory Board Membership - Abbott, Boehringer Ingelheim, Medtronic, Novartis, and Respicardia; and Editorial Board Involvement – JACC-HF, JWC, PACE. His presentation will not
include discussion of unapproved or “off-label” usage of commercial products and/or devices.
Ralph Augostini, MD, discloses he has relationships with commercial interests in the following
areas: Grant/Research Support - Respicardia; and Consultant/Speaker Bureau – Respicardia. His presentation will not include discussion of unapproved or “off-label” usage of commercial products and/or devices.
Sanjaya Gupta, MD, discloses he has relationships with commercial interests in the following
areas: Grant/Research Support – Bristol-Myers-Squibb, Medtronic, and Abbott/St. Jude Medical; Honorariuim Recipient - Boston Scientific and Medtronic. His presentation will not include discussion of unapproved or “off-label” usage of commercial products and/or devices.
Jagmeet Singh, MD, discloses he has relationships with commercial interests in the following
areas: Consultant/Speaker Bureau – Medtronic, Abbott, Biotronk, Boston Scientific, LivaNova, and Respicardia. His presentation will not include discussion of unapproved or “off-label” usage of commercial products and/or devices.
Dates and Times
End Date: 10/17/2021
Objectives
At the conclusion of this activity, participants should be able to:
- Inform clinicians about the prevalence of central sleep apnea in patients with heart failure and atrial fibrillation.
- Update clinicians on treatment options and benefits of treatment.
- Improve the understanding of the techniques and skill needed for implantation of phrenic nerve stimulation systems.
Internet Enduring Material Files
Speakers
Accreditation Statement
The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Ohio State University designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.